BLUE — bluebird bio Cashflow Statement
0.000.00%
Last trade - 00:00- $194.16m
- $19.87m
- $3.60m
- 47
- 25
- 19
- 21
Annual cashflow statement for bluebird bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -556 | -790 | -619 | -819 | -267 |
| Depreciation | |||||
| Non-Cash Items | 106 | 162 | 158 | 146 | -52.3 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 19.2 | 46.1 | -28.9 | 18 | -39.1 |
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -413 | -564 | -470 | -636 | -353 |
| Capital Expenditures | -55.7 | -76.3 | -29 | -23 | -13.2 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -624 | 584 | -55.4 | 586 | 264 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -679 | 508 | -84.3 | 563 | 250 |
| Financing Cash Flow Items | 3.1 | 0 | — | -174 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 738 | 21.2 | 547 | -94 | 54.3 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -355 | -35.4 | -7.98 | -167 | -48.2 |